1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsTCA awarded over $600,000 in grants to 96 organizations, including six equine-assisted therapy programs.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Nonprofits providing equine-assisted therapy programs. Confirm the full requirements in the official notice before applying.
TCA Awards 2026 Grants is funded by Thoroughbred Charities of America (TCA). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Community Rewards Giving Program is a grant from the Nusenda Foundation that strengthens communities across New Mexico by supporting nonprofits and public schools working to improve people's lives. The program is the Foundation's primary giving vehicle and awards grants of $2,500 to $15,000. Eligible applicants are 501(c)(3) nonprofits and public schools serving New Mexico communities. Applications for the most recent cycle closed March 31, 2026. The Nusenda Foundation's giving philosophy emphasizes community-driven impact aligned with the credit union's values of shared purpose and collective well-being.
Innovation Grant is a grant from the Blue Cross and Blue Shield of Louisiana Foundation that funds nonprofit organizations in Louisiana developing innovative, health-focused programs that improve the wellness and well-being of Louisianians. The foundation prioritizes creative approaches to addressing health disparities and improving access to health services for underserved populations. Eligible applicants are 501(c)(3) nonprofits based in Louisiana. Awards range from $10,000 to $100,000, with project eligibility and scope evaluated through a Letter of Intent (LOI) submission process. As of 2025, LOI submissions are completed through the lablue.smartsimple.com portal. The deadline for the most recent cycle was March 1, 2026.
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:• The Established Investigator category is for independent investigators at all academic levels, or equivalent• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Established Investigators.Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required for all applications. Clinical trials or clinical trial aims are not allowed. Funding Opportunity Number: HT942526DMDRPIDA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $2.5M total program funding.